Cancer

RSS

Banyu developing new anticancer agent

June 4, 1997

RCT issued U.S. patent for azonafide compounds

June 3, 1997

Receptagen receives notice of allowance of U.S. patent for "growth blocker" technology

June 3, 1997

Alpha Therapeutic and Techniclone report milestone in LYM-1 clinical development

June 3, 1997

Schering-Plough's Fareston approved by the FDA

June 3, 1997

Nippon Kayaku discovers new antitumor agent

June 3, 1997

CAAX-based protein farnesyltransferase inhibitors from Merck & Co.

June 3, 1997

Ludwig Institute describes new tumor rejection antigens

June 3, 1997

Identification of novel polyamine compounds with anticancer activity

June 3, 1997

Lilly and Megabios enter gene-based therapeutics collaboration

June 2, 1997